XML 29 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share Based Compensation
9 Months Ended
Sep. 30, 2012
Share Based Compensation [Abstract]  
SHARE BASED COMPENSATION

NOTE 8 SHARE BASED COMPENSATION

A summary of option activity under our stock compensation plans as of September 30, 2012, and the changes during the first nine months of 2012 is presented below:

 

         

Options

  Number of Options  

Outstanding at December 31, 2011

    4,053,652  

Granted

    1,000  

Exercised

    —    

Forfeited

    (71,245

Expired

    (425,776
   

 

 

 

Outstanding at September 30, 2012

    3,557,631  
   

 

 

 
   

Exercisable at September 30, 2012

    3,263,774  
   

 

 

 

We granted options to purchase 1,000 shares at an exercise price of $1.89 during the first nine months of 2012, with an average fair value at the date of grant of $0.96. The grant becomes exercisable between one and three years after the date of grant. We estimate the fair value of each stock option on the date of grant using the Black-Scholes option-pricing formula and amortize expense over the option’s vesting period using the straight-line attribution approach.

A summary of our restricted stock awards as of September 30, 2012 and the changes during the first nine months of 2012 is presented below:

 

         

Awards

  Number of Awards  

Nonvested at December 31, 2011

    405,977  

Granted

    —    

Vested

    (290,695

Forfeited

    (16,220
   

 

 

 

Nonvested at September 30, 2012

    99,062  
   

 

 

 

Share-based compensation expense for the three months ended September 30, 2012 and September 24, 2011 was $1.2 million and $0.8 million, respectively. Share-based compensation expense for the nine months ended September 30, 2012 and September 24, 2011 was $2.8 million and $2.0 million, respectively. The share-based compensation expense for the three and nine months ended September 30, 2012 reflect $1.0 million and $1.3 million, respectively of share-based expense relating to the modification of terms of certain outstanding stock options and restricted stock awards. The modifications included accelerated vesting and extended exercise periods related to certain employee terminations.